- Supported exchanges /
- TWO /
- 6875.TWO
Pharmosa Biopharm Inc. (6875 TWO) stock market data APIs
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Pharmosa Biopharm Inc. Financial Data Overview
| 63.5 | |
| 63.1 | |
| - | |
| 64.3 | |
| 63 | |
| 48.25-125.5 | |
| 8 193 M | |
| 181.4286 | |
| 129 M | |
| 324 M | |
| 0.516 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Pharmosa Biopharm Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 324 M
- EBITDA -566 000
- Earnings Per Share 0.35
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Pharmosa Biopharm Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Pharmosa Biopharm Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
